Business Standard

Markets likely to open higher; All eyes on US Fed

The early indicator, SGX Nifty is trading at 0.3% higher

Markets likely to open higher; All eyes on US Fed

SI Reporter Mumbai
Markets are expected to open the truncated week on a cheerful note mirroring the cues from global markets. The early indicator, SGX Nifty is trading at 0.3% higher.

Last week, S&P 500 index registered its best weekly gain in almost a year. Taking cues from the rally in US markets, Asia opened higher on Monday. Major Asian indices are trading up between 0.1-0.8 % higher.  However, HangSeng is down 0.1%

Also, the market players will have their eyes on the US Federal Reserve, which has called an unscheduled meeting on today.

In an absence of any immediate domestic data, the market players are expected to react to the winter session of Parliament, which will commence on Thursday November 26, 2015. The monsoon session of the Parliament was a complete washout hence the investors would be hoping to see the key legislative bills such as Goods and Services Tax (GST) sail through in this session.
 
This week markets are expected to also remain volatile on account of the derivatives expiry for the month of November.  

Meanwhile, the European equities finished on almost a three month high on the back of comments from the European and American central bankers.

STOCKS IN NEWS

M&M, TATA MOTORS: Mahindra & Mahindra (M&M) has managed to go past Tata Motors and take the top position for light commercial vehicles market.

Axis Bank: Axis Bank has opened a representative office in Dhaka, capital city of Bangladesh thus extending its overseas arm.

SBI, United Breweries: State Bank of India (SBI) has declared industrialist Vijay Mallya a 'wilful defaulter' for defaults on nearly Rs 7,000 crore loans to the long-grounded Kingfisher Airlines. Vijay Mallya is a holder of United Breweries.

Zee Entertaintment: Zee Entertainment Enterprises has become the first Indian media and entertainment firm to foray into theatre production and will start rolling out plays on Zee Theatre from December 25

Aurobindo Pharma: The drug company has received approval from the USFDA to manufacture and market generic version of Pfizer's Revatio tablets that are used in the treatment of high blood pressure in lungs.

Britannia Industries: Britannia Industries is embarking on a new growth path of becoming a total food company, aiming at Rs 20,000 crore turnover within 5-6 years.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 23 2015 | 8:37 AM IST

Explore News